UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
UltraClear has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
UltraClear's investors include Accelmed, 3E Bioventures.
UltraClear is headquartered in Smithfield, United States.
UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
UltraClear is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"UltraClear — Funding & Investors." VCBacked, May 29, 2025, https://www.vcbacked.co/company/ultraclear. Accessed October 29, 2026.
VCBacked. (2025). UltraClear — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/ultraclear
{{cite web |title=UltraClear — Funding & Investors |url=https://www.vcbacked.co/company/ultraclear |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated